je.st
news
Merck faces probe into asthma drug pricing
2015-11-06 23:06:05| Biotech - Topix.net
Merck & Co. Inc.'s stock dropped 1.5% in midday trade Friday, after the drug maker disclosed in a filing late Thursday that it had received a civil investigative demand from the U.S. Attorney's office.
Tags: drug
pricing
faces
probe
Category:Biotechnology and Pharmaceuticals